id
name
related bits
0
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
27 (unknown)
first seen date
2024-03-03 06:23:44
expired found date
-
created at
2024-06-26 18:22:05
updated at
2026-01-03 23:23:53
length
14
crc
13858
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
NGINX
server ip
mp import status
20
mp rejected date
-
mp saved date
2025-12-19 00:50:10
mp size orig
55291
mp size raw text
9212
mp inner links count
0
mp inner links status
20 (imported)
title
description
세계 최초의 자폐스펙트럼장애 치료제 개발을 위한 후보물질(NV01-A02) 개발 및 FDA 희귀의약품 지정에 성공한 뉴로벤티(NeuroVenti)는 특허청으로부터 자폐스펙트럼장애를 비롯한 정서장애 치료에 관한 신규 특허 등록을 통보 받아 현재 자폐스펙트럼장애 치료제의 국내 임상 2상 진행중으로, 중추신경계 장애에 대한 치료제 후보 발굴, 비임상 연구 컨설팅
image
site name
author
updated
2026-01-01 23:57:12
raw text
뇌질환의 혁신, 뉴로벤티(NeuroVenti) 팝업레이어 알림 팝업레이어 알림이 없습니다. 뇌질환의 혁신, 뉴로벤티(NeuroVenti) Toggle navigation About Overview Vision/Mission Greetings History CI Science&Technology Science Pipeline R&D Services Non-clinical CDRO Application process News News/Notice Information Contact Contact Us KOR INNOVATING TREATMENT FOR BRAIN DEVELOPMENTAL DISORDERS Development of patient-customized novel drugs for optimal brain function utilization more DISCOVERING CANDIDATES FOR OPTIMIZED BRAIN DISEASE TREATMENT Provision of customized solutions for intractable brain diseases more INTEGRATING PLATFORMS OF TREATMENT FOR BRAIN DISEASES Holistic approach to brain well-being from cradle to grave more NeuroVenti NeuroVenti is a global biotech startup leading the development of neuroprotective and therapeutic agents against neuronal disorders. 세계 최초의 자폐스펙트럼장애 치료제 개발을 위한 후보물질(NV01-A02) 개발 및...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
Medicine [en] (226)
index version
2025123101
spam phrases
0
text nonlatin
274
text cyrillic
0
text characters
7060
text words
1219
text unique words
579
text lines
174
text sentences
38
text paragraphs
9
text words per sentence
32
text matched phrases
16
text matched dictionaries
5
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
0 (new)
sitemap review version
2
sitemap urls count
0
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
-
sitemap process date
-
sitemap first import date
-
sitemap last import date
-